BioAge Labs, Inc. (BIOA)
5.87
-0.07
(-1.18%)
USD |
NASDAQ |
Oct 30, 16:00
5.90
+0.03
(+0.51%)
After-Hours: 20:00
BioAge Labs Market Cap : 268.71M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 268.71M |
| October 29, 2026 | 271.91M |
| October 28, 2026 | 271.91M |
| October 27, 2026 | 250.40M |
| October 26, 2026 | 228.43M |
| October 23, 2026 | 233.46M |
| October 22, 2026 | 253.15M |
| October 21, 2026 | 252.23M |
| October 20, 2026 | 254.52M |
| October 19, 2026 | 228.43M |
| October 16, 2026 | 221.56M |
| October 15, 2026 | 244.91M |
| October 14, 2026 | 248.11M |
| October 13, 2026 | 254.98M |
| October 12, 2026 | 271.91M |
| October 09, 2026 | 290.23M |
| October 08, 2026 | 284.27M |
| October 07, 2026 | 286.56M |
| October 06, 2026 | 287.94M |
| October 05, 2026 | 291.14M |
| October 02, 2026 | 302.59M |
| October 01, 2026 | 311.74M |
| September 30, 2026 | 324.56M |
| September 29, 2026 | 326.85M |
| September 28, 2026 | 328.68M |
| Date | Value |
|---|---|
| September 25, 2026 | 322.73M |
| September 24, 2026 | 330.05M |
| September 23, 2026 | 361.18M |
| September 22, 2026 | 387.27M |
| September 21, 2026 | 370.34M |
| September 18, 2026 | 368.96M |
| September 17, 2026 | 370.34M |
| September 16, 2026 | 354.77M |
| September 15, 2026 | 374.46M |
| September 14, 2026 | 388.19M |
| September 11, 2026 | 388.65M |
| September 10, 2026 | 395.97M |
| September 09, 2026 | 419.77M |
| September 08, 2026 | 430.07M |
| September 04, 2026 | 439.00M |
| September 03, 2026 | 434.88M |
| September 02, 2026 | 445.41M |
| September 01, 2026 | 435.80M |
| August 31, 2026 | 434.88M |
| August 28, 2026 | 441.75M |
| August 27, 2026 | 461.43M |
| August 26, 2026 | 450.44M |
| August 25, 2026 | 462.80M |
| August 24, 2026 | 429.39M |
| August 21, 2026 | 433.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neumora Therapeutics, Inc. | 68.61M |
| Alumis, Inc. | 864.84M |
| ANI Pharmaceuticals, Inc. | 1.654B |
| Corcept Therapeutics, Inc. | 8.755B |
| Veru, Inc. | 37.34M |
Market Cap Related Metrics
| PS Ratio | 22.57 |
| PEG Ratio | -0.3644 |
| Price to Book Value | 0.7167 |
| Price | 5.87 |
| Earnings Yield | -40.66% |
| PEGY Ratio | -0.3644 |